Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHTCF.L Regulatory News (HTCF)

  • There is currently no data for HTCF

Succession Planning Update

16 Jul 2015 17:20

RNS Number : 3057T
BlueCrest AllBlue Fund Ltd
16 July 2015
 



16 July 2015

 

BLUECREST ALLBLUE FUND LIMITED (THE 'COMPANY')

 

SUCCESSION PLANNING UPDATE

 

In the Annual Financial Report for the year ended 31 December 2014 (the "AFR"), the Company advised that it was scheduled to consider the tenure of directors once any director has been appointed to the Board for a continuous period of nine years and that this would occur in 2015 for Messrs Crowder, Meader and Le Prevost, with the intention that in order to achieve orderly succession and to retain 'corporate memory', it is the intention of the Board that one of each of the above three directors should step aside in each calendar year starting in 2015. Notwithstanding their nine years service the Company considers that Richard, Paul and John remain able to act independently.

 

Further to this disclosure, investors may have noted that the Company has appointed Miss Sarita Keen as an independent non executive director effective 3 June 2015. Sarita brings an in depth knowledge of Guernsey fund administration and has already made a valuable contribution to the Board.

 

In line with the succession plan disclosed in the AFR it is the intention of the Company that Sarita takes on the duties of John Le Prevost in due course and that John Le Prevost will be the first of the three directors named above to retire. The Company anticipates that this will occur before the end of the year.

 

The Board believes that one of the distinctions of an investment company such as BCAB is that there are no executives or investment managers to carry out duties such as monitoring the valuation process, cash pot policy and conversion mechanism. For the Company the failure of any of these mechanisms is a significant risk and many of these procedures (for instance inter share class conversions) take place over a period of some 6-8 weeks, and so the Board considers that a 5 month handover period is not excessively long. However, five months is the anticipated maximum in this case.

 

The Board is also actively seeking a replacement for Richard Crowder, as chairman. Next year the Board will review the position of Paul Meader, in line with the succession plan.

 

For further information about this announcement contact:

 

JTC (Guernsey) Limited

Secretary

Tel: +44 (0) 1481 702 400

E&OE - in transmission

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STRQQLFFEDFBBBK
Date   Source Headline
6th Jun 20193:29 pmRNSNet Asset Value(s)
5th Jun 20194:54 pmRNSTransaction in Own Shares
4th Jun 20195:14 pmRNSTransaction in Own Shares
29th May 20195:06 pmRNSChange of Company Secretary and Registered Office
29th May 20194:59 pmRNSTransaction in Own Shares
29th May 20191:41 pmRNSNet Asset Value(s)
24th May 20195:13 pmRNSTransaction in Own Shares
22nd May 20195:00 pmRNSTransaction in Own Shares
22nd May 20191:34 pmRNSNet Asset Value(s)
21st May 20195:11 pmRNSTransaction in Own Shares
21st May 20194:59 pmRNSHolding(s) in Company
21st May 20191:47 pmRNSNet Asset Value(s)
16th May 20195:35 pmRNSTransaction in Own Shares
14th May 20195:28 pmRNSTransaction in Own Shares
14th May 20191:10 pmRNSNet Asset Value(s)
3rd May 201911:47 amRNSNet Asset Value(s)
30th Apr 201912:04 pmRNSNet Asset Value(s)
24th Apr 201912:50 pmRNSNet Asset Value(s)
23rd Apr 20191:34 pmRNSNet Asset Value(s)
16th Apr 201912:41 pmRNSNet Asset Value(s)
16th Apr 20197:00 amRNSAnnual Financial Report
5th Apr 20194:29 pmRNSHolding(s) in Company
3rd Apr 20191:05 pmRNSNet Asset Value(s)
2nd Apr 20191:50 pmRNSHolding(s) in Company
26th Mar 201912:16 pmRNSNet Asset Value(s)
26th Mar 20199:42 amRNSStatement re : Liquidation of AllBlue Funds
25th Mar 20195:23 pmRNSTransaction in Own Shares
22nd Mar 201912:46 pmRNSNet Asset Value(s)
21st Mar 20199:24 amRNSHolding(s) in Company
19th Mar 20191:25 pmRNSNet Asset Value(s)
12th Mar 20195:23 pmRNSTransaction in Own Shares
12th Mar 201911:36 amRNSNet Asset Value(s)
11th Mar 201912:25 pmRNSHolding(s) in Company
8th Mar 20195:07 pmRNSTransaction in Own Shares
5th Mar 20191:18 pmRNSNet Asset Value(s)
27th Feb 201912:47 pmRNSNet Asset Value(s)
26th Feb 201910:46 amRNSNet Asset Value(s)
22nd Feb 201910:19 amRNSHolding(s) in Company
20th Feb 20199:41 amRNSNet Asset Value(s)
15th Feb 20194:52 pmRNSStatement re Membership of Audit Committee
12th Feb 201911:13 amRNSNet Asset Value(s)
5th Feb 201912:13 pmRNSNet Asset Value(s)
4th Feb 20195:27 pmRNSTransaction in Own Shares
30th Jan 201911:24 amRNSNet Asset Value(s)
29th Jan 201911:20 amRNSNet Asset Value(s)
23rd Jan 201911:39 amRNSNet Asset Value(s)
16th Jan 201912:26 pmRNSNet Asset Value(s)
10th Jan 20195:18 pmRNSTransaction in Own Shares
9th Jan 20195:29 pmRNSTransaction in Own Shares
8th Jan 20195:01 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.